Reapplix is currently owned by Lauxera Capital Partners, through Lauxera Growth I, since 2023.

When did Lauxera Capital Partners acquire Reapplix?

Lauxera Capital Partners acquired Reapplix in 2023 (active for 3 years).

Home/Companies/Healthcare/Reapplix

Reapplix

Healthcare·

Denmark·Active·3yr hold

Reapplix is a healthcare company, headquartered in France.

Entry

2023

Hold

3yr

Status

Active

Est. EV

–

Investor

Lauxera Capital Partners

Key facts

HQFrance

SectorHealthcare

Denmark-based advanced wound-care and regenerative-medicine biotech; backed by Lauxera Capital Partners in the EUR 22.6M financing…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Lauxera Growth I

Other portfolio companies in the same fund.

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.

Last updated April 2026 · Sourced from public filings